文献速递产科麻醉术前评估与围术期医学区域麻醉与超声

妊娠期高血压疾病合并血小板减少剖宫产全麻的多中心观察研究

General Anesthesia for Cesarean Delivery for Thrombocytopenia in Hypertensive Disorders of Pregnancy: Findings From the Obstetric Airway Management Registry.
PubMed 文献 · Anesth Analg · 2022-10-13

基于南非开普敦大学附属麻醉培训机构的产科气道管理登记(ObAMR),多中心回顾性观察591例剖宫产,其中16.9%因血小板减少选择全麻,8.8%为疑似血小板减少且因实验室结果不可用而全麻;疑似组可追溯者中89.1%血小板实际超过75×10^9/L。

要点

  • 妊娠期高血压疾病剖宫产全麻中,血小板减少是常见指征。
  • 疑似血小板减少全麻者多数实际血小板计数可安全实施椎管内麻醉。
  • 早期实验室评估有助于避免不必要的全麻。

核心结论

  • 591例中16.9%因血小板减少选择全麻,其中52例(8.8%)因血小板计数不可用而全麻。
  • 若已知血小板计数,41例(6.9%)血小板超过75×10^9/L者无需全麻。

研究设计与样本

  • 多中心观察性研究,基于产科气道管理登记(ObAMR),覆盖开普敦大学附属所有麻醉培训机构。
  • 共纳入591例剖宫产患者,回顾性检索疑似血小板减少者的后续血小板计数。

主要发现

  • 全麻指征为血小板减少者100/591(16.9%),其中91例合并妊娠期高血压疾病。
  • 确诊血小板减少组48/591(8.1%),全麻指征为血小板计数<75×10^9/L。
  • 疑似血小板减少组52/591(8.8%),46例可追溯,中位血小板计数178×10^9/L(IQR 93-233),41/46(89.1%)超过75×10^9/L。
  • 5例回顾性确诊血小板减少者中,2例HELLP综合征,2例产前出血合并子痫前期,1例孤立性血小板减少合并子痫前期。

关键数值与推荐

  • 确诊血小板减少组全麻指征为血小板计数<75×10^9/L。
  • 疑似组可追溯者中位血小板计数178×10^9/L(IQR 93-233×10^9/L),89.1%超过75×10^9/L。

临床怎么用

  • 妊娠期高血压疾病患者剖宫产前应尽早评估血小板计数,以指导麻醉方式选择。
  • 当血小板计数不可用时,可参照所提出的算法与决策辅助工具权衡椎管内麻醉与全麻的风险获益。
  • 在特定情况下,即使有指征但血小板计数不可用,临床医生仍可合理选择椎管内麻醉。

局限性

  • 回顾性观察设计,疑似组血小板计数追溯不完全(46/52可追溯)。
  • 研究环境为资源有限地区,实验室服务不可用或不在现场,结果外推需谨慎。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: In resource-limited environments, spinal anesthesia (SA) is preferred for cesarean delivery. In women at risk of spinal epidural hematoma, particularly those with hypertensive disorders of pregnancy, thrombocytopenia should be excluded before neuraxial blockade. In the context of emergency surgery for fetal distress, this investigation may be hampered by laboratory services being unavailable or off-site. METHODS: The Obstetric Airway Management Registry (ObAMR) is currently active across all anesthesia training institutions affiliated with the University of Cape Town. This multicenter observational study aimed to estimate the proportion of patients receiving general anesthesia (GA) for either confirmed or suspected thrombocytopenia, which was not excluded due to unavailability of laboratory results. To establish the number of GA uses that may have been avoided if platelet counts were available, we retrospectively searched for subsequent platelet counts in patients for whom thrombocytopenia was suspected. An algorithm was proposed, including a simple decision aid for estimating risk versus benefit of SA versus GA, to be followed in the setting of hypertensive disorders of pregnancy and thrombocytopenia. RESULTS: Thrombocytopenia was the indication for GA in 100 of 591 patients (16.9%) captured in the registry. In total, 48 of 591 (8.1%) had confirmed thrombocytopenia, and 52 of 591 (8.8%) had suspected thrombocytopenia. Of these patients, 91 of 100 had a hypertensive disorder of pregnancy. In the confirmed thrombocytopenia group, the indication for GA was a platelet count <75 × 10 9 /L. In the suspected thrombocytopenia group, 46 of 52 (88.5%) platelet counts could be retrospectively traced. The median (interquartile range) platelet count was 178 × 10 9 /L (93 - 233 × 10 9 /L), and platelets exceeded 75 × 10 9 /L in 41 of 46 patients (89.1%). In the 5 of 46 patients with retrospectively confirmed thrombocytopenia, 2 had hemolysis, elevated liver enzymes, and low platelets (HELLP) syndrome, 2 had antepartum hemorrhage with preeclampsia, and 1 had isolated thrombocytopenia with preeclampsia. CONCLUSIONS: In 17% of patients, the indication for GA was thrombocytopenia. Of these, 52 of 100, or nearly 9% of the total of 591, received GA because a platelet count was unavailable at the time of surgery. The importance of early laboratory assessment, when available, should be emphasized. Overall, 41 of 591 (6.9%) had a platelet count >75 × 10 9 /L and would not have needed GA if their platelet count had been known. After following the constructed algorithm and applying the decision aid to assess risk and benefit, there may be circumstances in which the clinician justifiably opts for SA when a platelet count is indicated but unavailable.

来源:Anesth Analg,查看原文。版权归原作者所有。

引用

  1. Seymour LM, Fernandes NL, Dyer RA, et al. General Anesthesia for Cesarean Delivery for Thrombocytopenia in Hypertensive Disorders of Pregnancy: Findings From the Obstetric Airway Management Registry. Anesth Analg. 2022. PMID: 36731022. doi:10.1213/ANE.0000000000006217

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。